electroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
Sign up today and learn more about electroCore Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About electroCore Stock
electroCore LLC is a U.S.-based neuroscience and bioelectronic medicine healthcare technology company dedicated to improving patient outcomes through technological advancement. The company is focused on developing its proprietary non-invasive Vagus Nerve Stimulation (nVNS) therapies for the treatment of multiple conditions in neuropsychology, metabolic disorders and immunology. The company’s initial target is the treatment of primary headache, specifically migraine and cluster headache, and the associated chronic co-morbidities of gastric motility, psychiatric, sleep, and pain disorders that drive disproportionately large direct and indirect costs within the healthcare system and society.
Chief Medical Officer
Peter S. Staats, MD
Chief Executive Officer
Global Vice President, Sales and Marketing
Vice President, Quality Assurance
Co-Founder, Chief Science & Strategy Officer
J. P. Errico
Vice President, Scientific, Medical and Governmental Affairs
Co-Founder and Chief Technical Officer
Chief Financial Officer
Glenn S. Vraniak
Vice President, Research
Bruce J. Simon, PhD
BangaloreWeekly - Jun, 27 2018Electrocore (ECOR) Reaches New 52-Week High After Insider Buying Activity
StockNewsTimes - Jun, 27 2018Global Health Innovation Merck Buys 166666 Shares of Electrocore LLC (ECOR) Stock
GlobeNewswire (press release) - Jun, 26 2018electroCore, Inc. Announces Closing of Initial Public Offering
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase